AP
About
Adamis Pharmaceuticals is a clinical-stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a variety of neuro-based disorders with significant unmet medical needs. It commercializes products in various therapeutic areas, including allergy, opioid overdose, and respiratory and inflammatory diseases.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 829 investors are based in San Diego, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- San Diego, US
Contact Information
Find more investors like Adamis
Search Investors